RecruitingNCT07100288

Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer


Sponsor

Complejo Hospitalario Universitario Insular Materno Infantil

Enrollment

200 participants

Start Date

Jul 20, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
  • FIGO 2014 stage IA-IVB.
  • Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
  • Patients with no residual disease after surgery.
  • Patients with ECOG performance status 0-1.

Exclusion Criteria4

  • ◦ Patients without epithelial ovarian cancer.
  • Patients with ECOG 2-4.
  • Patients who do not consent to participate in the study.
  • Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.

Interventions

OTHERresection of infundibulopelvic ligament

Therefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients


Locations(1)

Complejo Universitario Insular Materno Infantil de Las Palmas

Las Palmas de Gran Canaria, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07100288


Related Trials